MSCA-Doctoral Network PhD position: Phenotypic and molecular changes driven by β-catenin inhibitors in colorectal cancer (CRC)

Training program to engage flexible and disordered protein targets for therapeutic development: The oncogene β-catenin as showcase University Medical Center Amsterdam Dr. Nicolas Leveille Objectives: 1. Evaluate the influence of β-catenin inhibitors on the Wnt pathway. 2. Assess phenotypic and transcriptional changes of β-catenin inhibitors in a panel of CRC cell lines. 3.